Effects of Different Immunosuppressive Drugs on Incretins in Renal Transplant Patients

YILMAZ N., SARI R., SÜLEYMANLAR G., ÖZDEM S.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, cilt.112, sa.3, ss.250-257, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 112 Sayı: 3
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1016/j.jnma.2020.03.012
  • Dergi Adı: JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, CAB Abstracts, CINAHL, EMBASE, Gender Studies Database, International Pharmaceutical Abstracts, MEDLINE, Psycinfo, Veterinary Science Database
  • Sayfa Sayıları: ss.250-257
  • Anahtar Kelimeler: Incretin, Glucagon-like peptide-1, Glucose dependent insulinotropic polypeptide, Post-transplant diabetes, Renal transplantation, GLUCAGON-LIKE PEPTIDE-1, INSULIN SENSITIVITY, SECRETION, GLUCOSE, RELEASE
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Background: Immunosuppressive drugs used in transplantation patients, may contribute to the development of post-transplant diabetes mellitus through their possible adverse effects on incretins. We aimed to compare the effects of different immunosuppressive drugs used in renal transplantation patients on glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) levels.